Company: IXHL
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001213900-25-036057
Chunk: 36

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 36
---
arrants and Series A Warrants) outstanding to purchase an aggregate of 3,017,095shares of common stock with a weighted average exercise price of $13.75 per share, (iv) 2,550,548shares of common stock reserved for issuance pursuant to future grants under our equity incentive plans, (v) 1,887,045shares of common stock issuable upon exercise of outstanding Pre -FundedWarrants, (vi) seven shares of our common stock are reserved for issuance under our April 7, 2025 at -the -marketoffering Sales Agreement with A.G.P./Alliance Global Partners and (vii) up to 347,222,700shares of common stock issuable upon exercise of the Series A Warrants assuming full adjustment of the exercise price to the Floor Price, approval of the Warrant Stockholder Approval in Proposal No. 1 and this Proposal No. 2 and exercise pursuant to their zero exercise price provisions. Pursuant to Proposal No.3, we are also seeking approval of an amendment to our 2023 Plan to (x) increase the number of shares authorized for the issuance of awards by 2,700,000 and (y) to incorporate an evergreen provision to increase the number of shares under the 2023 Plan in future years (20% of our then -outstandingshares of Common Stock on September 30, 2025 and 5% of our then -outstandingshares of Common Stock on the first day of each Fiscal Year from 2026 through 2032). Following the approval and filing of the Certificate of Amendment, we may explore additional financing opportunities or strategic transactions that would require the issuance of additional shares of our common stock, but no such plans are currently in existence and we have not begun any negotiations with any party related thereto. If we issue additional shares, the ownership interest of holders of our capital stock will be diluted. Other than as set forth above or elsewhere in this proxy statement, we have no current plans, proposals or arrangements to issue any of the additional authorized shares of common stock that would become available as a result of the filing of the Certificate of Amendment. Interest of Certain Persons in Matters to Be Acted Upon Except with respect to their continued employment as officers or directors of the Company, no director or executive officer has any substantial interest, direct or indirect, by security holdings or otherwise, in this Proposal that is not shared by all of our other stockholders. 20 Procedure for